Fig. 1 | Scientific Data

Fig. 1

From: A single-cell RNA sequencing dataset of peripheral blood cells in long COVID patients on herbal therapy

Fig. 1

Workflow of the study. Data from 16 participants who were allocated into herbal medicine treatment groups were obtained during the participation of a clinical trial. Intervention used in this clinical trial included treatments with commercially available herbal medications for 12 weeks. Blood samples were taken for scRNA-seq, and CIS score was measured to monitor the outcome of the treatment. Peripheral whole blood cells were extracted from the collected blood specimens by RBC lysis. After cell viability assessment, the samples were labelled and grouped for a multiplexed sequencing analysis. Library preparation and data pre-processing was conducted according to BD Rhapsody protocol. For downstream bioinformatic analysis, R Seurat package was utilized to perform additional QC, cluster, and annotate the cells.

Back to article page